Pearce IP and its team members are ranked in virtually every notable legal and attorney listing for Australia. We have been honoured with many awards recognising the talent of our team members and the standard of excellence Pearce IP has set for the provision of legal and IP services in Australia and New Zealand.
Pearce IP’s Founder and CEO Naomi Pearce is a finalist in two categories of the 2025 Lawyers Weekly Partner of the Year Awards: Senior Partner of the Year – 15 Years or More Intellectual Property Partner of the Year...
Two Pearce IP leaders have been ranked in the WIPR Diversity & Inclusion Top 100 People in IP for 2025. This annual list honours and celebrates the world’s “top 100” intellectual property leaders making a tangible...
Founder and CEO Naomi Pearce has been recommended in the 2025 NSW Leading Contentious IP Lawyers List in the Doyles Guide for Australia released on 24 April. Doyle’s Guide is an independent listing based on client and...
We are delighted to share that Helen Macpherson, Pearce IP’s Executive Lawyer and Head of Litigation (Australia) has again been ranked in the 2026 edition of The Best Lawyers in Australia in the categories of IP Law...
We are delighted to announce that Pearce IP has been ranked for the second time in the prestigious Chambers Asia-Pacific and Global 2025 rankings for Intellectual Property (Australia). This recognition highlights our ongoing commitment to providing world-class intellectual property services, particularly in the pharmaceutical, biopharmaceutical, and life sciences sectors.
We are delighted to announce that Pearce IP’s Founder & CEO, Naomi Pearce, was named Executive of the Year at the 2024 Lawyers Weekly Women in Law Awards. The Women in Law Awards recognise “the influence of...
Pearce IP has earned double recognition in the fourth annual Australasian Lawyer 2024 "Elite Women" list, with 2 of its Executives recognised amongst the top 50 female leading the legal industry in Australia. Pearce...
We are thrilled to share that Pearce IP’s Founder and CEO, Naomi Pearce, a Finalist in the Lawyers Weekly Women in Law Awards 2024 “Executive of Year”. Now in its 13th year, the Women in Law Awards celebrates the best...
We congratulate Naomi Pearce, Pearce IP’s CEO and Founder (Lawyer, Patent and Trade Mark Attorney) on her 2024 IAM Strategy 300 ranking in three categories: Legal; Pharmaceuticals/Life Sciences; and IP Management...
We are delighted to announce that Pearce IP’s founder and CEO, Naomi Pearce, has been honoured by Australasian Lawyer in The Most Influential Lawyers in Australia list for 2024. Included in Australasian Lawyer’s...
WIPR Leaders released its annual global guide to the world’s leading practitioners last week, and we are delighted to have 10 Pearce IP leaders across Australia and New Zealand ranked for patents and/or trade marks for...
We are thrilled to announce that Pearce IP has been honoured as Australasian Lawyer’s 2024 The Best Boutique Intellectual Property Law Firms in Australia!
Subscribe to our Pearce IP Blogs and BioBlast® to receive our updates via email.
Global - Intellectual Property (2025)
Asia Pacific - Intellectual Property (2025)
Asia Pacific - Intellectual Property (2024)
Market Leading Intellectual Property Firm (2025)
Market Leading Intellectual Property Firm (2024)
Market Leading Intellectual Property Firm (2023)
Tier 3 for IP Proscecution (2024)
Tier 3 for IP Proscecution (2023)
Bronze for litigation (2023, 2022, 2021)
Bronze for prosecution (2024, 2023, 2022, 2021)
Finalist – Women in Law Awards – Boutique Diversity Firm of the Year (2022)
Finalist – Intellectual Property Team of the Year (2022)
Winner – Intellectual Property Team of the Year (2021)
Patent Prosecution (2024, 2023, 2022)
The Only Leading Female Owned Life Sciences focussed IP Firm (2023)
Pearce IP ranked firm (2021)
Silver - Litigation & Prosecution Australia (2025)
Bronze - Litigation & Prosecution New Zealand (2025)
Litigation & Prosecution Australia (2024)
Shortlisted – Australian Firm of the Year (2022)
Australasia – Healthcare & Life Sciences (Q1 2025, Q2 2024, Q1 2024, Q4 2023, Q3 2023, Q2 2023, Q3 2022, Q2 2022, Q1 2021, Q4 2020)
Cross-border – Healthcare & Life Sciences (Q1 2025, Q2 2024, Q1 2024, Q4 2023, Q3 2023, Q2 2023, Q1 2023)
Europe – Healthcare & Life Sciences (Q1 2025)
Top Boutique Firm (2024)
5-Star Intellectual Property Law Firm (2021)
Doyles Leading Intellectual Property (2021, 2020)
Doyles Recommended Intellectual Property (2021)
Finalist – Intellectual Property Partner of the Year (2024)
Winner – Intellectual Property Partner of the Year (2023)
Finalist – Intellectual Property Partner of the Year (2022)
Intellectual Property: Patents – Global (2025)
Intellectual Property: Patents – Asia Pacific (2025)
Life Sciences - Asia Pacific (2025)
Intellectual Property: Patents – Asia Pacific (2024)
Life Sciences – Asia Pacific (2024)
Recommended - Leading Contentious Intellectual Property Lawyer in NSW (2025)
Most Influential Lawyers – Changemaker (2024, 2023, 2022)
5-Star Intellectual Property Lawyer – General IP (2021)
WIPR Leader (2024, 2023, 2022)
WIPR Diversity Champion (2025, 2022)
Top 100 Influential Women in IP (2021)
WIPR Leaders – Patents & Trade Marks (2022, 2021, 2020)
Silver ranking – Litigation (2024, 2023, 2022, 2021)
Recommended for litigation (2020)
IP management consultancy (2024)
Legal (2024)
Pharmaceuticals/life sciences (2024)
Global Leader (2022, 2021, 2020)
World Leading IP Strategist (2022, 2021, 2020)
Patent Star (2024, 2023, 2022, 2021)
Practitioner of the Year Finalist (2023)
Silver - Prosecution & Strategy (Australia) (2025)
Winner – Patent Lawyer of the Year (2022)
Shortlisted – Life Sciences Lawyer of the Year (2022)
Winner – Client Choice Award for Life Sciences (2022)
Winner - Executive of the Year (2024)
Finalist - Executive of the Year (2024)
Winner – Partner of the Year (SME Law) (2021)
Australasia - Dispute Resolution (Q1 2025)
Australasia – Healthcare & Life Sciences (Q3 2024, Q2 2024, Q4 2023, Q3 2023, Q2 2023, Q3 2022, Q2 2022, Q1 2021, Q4 2020, Q3 2020)
Asia-Pacific – Healthcare & Life Sciences (Q1 2024, Q4 2023, Q3 2023)
US – Healthcare & Life Sciences (Q4 2023, Q3 2023, Q2 2023)
Cross-border – Healthcare & Life Sciences (Q3 2024, Q2 2024, Q1 2024, Q4 2023, Q3 2023, Q2 2023, Q1 2023, Q4 2022, Q3 2021)
Canada – Healthcare & Life Sciences (Q4 2023, Q2 2023)
Europe – Healthcare & Life Sciences (Q4 2023)
WIPR Leader (2024)
Intellectual Property: Patents - Global (2025)
Intellectual Property: Patents - Asia Pacific (2025)
Intellectual Property: Patents - Asia Pacific (2024)
Patents Star (2024, 2023)
Silver ranking – Litigation (2024, 2023, 2022)
Silver ranking – Transactions (2024)
Ranked as a market leading Intellectual Property firm (2023)
Bronze - Enforcement & Litigation (Australia) (2025)
Intellectual Property (2026, 2025, 2024, 2023, 2022, 2021, 2020, 2019, 2018, 2017, 2016)
Life Sciences Practice (2026)
Patent Lawyer of the Year (2021)
WIPR Leader (2024)
Intellectual Property - Asia Pacific (2025)
Intellectual Property - Asia Pacific (2024)
Notable Practitioner (2024)
Litigation (2016 - 2024)
Bronze - Enforcement & Litigation (New Zealand) (2025)
Recommended individual – Enforcement & Litigation (2024, 2023, 2022)
IP Expert (2022)
Intellectual Property & Litigation (2024, 2023, 2022, 2019)
WIPR Leader (2024, 2023, 2022)
Patent Leader (2023, 2022, 2021)
Patent Star (2024, 2023, 2022, 2021, 2020)
Rising Star (2023)
Silver ranking – Prosecution (2024, 2023)
Highly Recommended – Prosecution (2023, 2022)
WIPR Leader (2024)
Committed Professional of the Year (2023)
Global Award for In-House Lawyer (2022)
Top 250 Women in IP (2019)
IP Star (2015 - 2019)
IP Specialist Practitioner – Finalist (2019)
Recognition as IP Practitioner – Recommended for Patent Prosecution (2012 – 2015)
Recognition as IP Practitioner – Excellence in Patent Work (2015, 2014)
WIPR Leader (2024)
Leading Next Generation Leaders (2025)
Rising Star in Intellectual Property (2024)
Rising Star in Intellectual Property (2023)
Rising Star in Intellectual Property (2022)
Rising Star in Intellectual Property (2021)
By 2027, be the premier life sciences IP practice in
Australia and New Zealand.